vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and FRANKLIN STREET PROPERTIES CORP (FSP). Click either name above to swap in a different company.
FRANKLIN STREET PROPERTIES CORP is the larger business by last-quarter revenue ($26.0M vs $19.2M, roughly 1.4× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -28.1%, a 21.3% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -8.2%). Apyx Medical Corp produced more free cash flow last quarter ($-2.8M vs $-12.7M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -8.7%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
APYX vs FSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $26.0M |
| Net Profit | $-1.3M | $-7.3M |
| Gross Margin | 62.6% | 59.4% |
| Operating Margin | 0.1% | -27.9% |
| Net Margin | -6.8% | -28.1% |
| Revenue YoY | 34.7% | -8.2% |
| Net Profit YoY | 71.9% | 14.1% |
| EPS (diluted) | — | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $26.0M | ||
| Q3 25 | $12.9M | $27.3M | ||
| Q2 25 | $11.4M | $26.7M | ||
| Q1 25 | $9.4M | $27.1M | ||
| Q4 24 | $14.2M | $28.4M | ||
| Q3 24 | $11.5M | $29.7M | ||
| Q2 24 | $12.1M | $30.8M | ||
| Q1 24 | $10.2M | $31.2M |
| Q4 25 | $-1.3M | $-7.3M | ||
| Q3 25 | $-2.0M | $-8.3M | ||
| Q2 25 | $-3.8M | $-7.9M | ||
| Q1 25 | $-4.2M | $-21.4M | ||
| Q4 24 | $-4.6M | $-8.5M | ||
| Q3 24 | $-4.7M | $-15.6M | ||
| Q2 24 | $-6.6M | $-21.0M | ||
| Q1 24 | $-7.6M | $-7.6M |
| Q4 25 | 62.6% | 59.4% | ||
| Q3 25 | 64.4% | 60.9% | ||
| Q2 25 | 62.3% | 59.9% | ||
| Q1 25 | 60.1% | 62.8% | ||
| Q4 24 | 63.0% | 59.7% | ||
| Q3 24 | 60.5% | 61.0% | ||
| Q2 24 | 61.7% | 64.2% | ||
| Q1 24 | 58.1% | 64.7% |
| Q4 25 | 0.1% | -27.9% | ||
| Q3 25 | -6.5% | -30.5% | ||
| Q2 25 | -22.6% | -29.2% | ||
| Q1 25 | -32.4% | -78.9% | ||
| Q4 24 | -21.4% | -29.9% | ||
| Q3 24 | -31.6% | -52.4% | ||
| Q2 24 | -45.7% | -68.0% | ||
| Q1 24 | -64.6% | -24.0% |
| Q4 25 | -6.8% | -28.1% | ||
| Q3 25 | -15.4% | -30.5% | ||
| Q2 25 | -33.2% | -29.5% | ||
| Q1 25 | -44.0% | -79.1% | ||
| Q4 24 | -32.5% | -30.0% | ||
| Q3 24 | -40.9% | -52.6% | ||
| Q2 24 | -54.0% | -68.2% | ||
| Q1 24 | -74.0% | -24.2% |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | $-0.19 | $-0.20 | ||
| Q1 24 | $-0.22 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $30.6M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $607.0M |
| Total Assets | $66.8M | $892.9M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $30.6M | ||
| Q3 25 | $25.1M | $31.4M | ||
| Q2 25 | $29.3M | $29.4M | ||
| Q1 25 | $31.0M | $30.2M | ||
| Q4 24 | $31.7M | $41.1M | ||
| Q3 24 | $28.0M | $40.9M | ||
| Q2 24 | $32.7M | $30.2M | ||
| Q1 24 | $37.3M | $34.2M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $607.0M | ||
| Q3 25 | $5.8M | $615.3M | ||
| Q2 25 | $7.3M | $624.7M | ||
| Q1 25 | $10.5M | $633.4M | ||
| Q4 24 | $14.2M | $655.9M | ||
| Q3 24 | $11.0M | $665.4M | ||
| Q2 24 | $14.7M | $682.1M | ||
| Q1 24 | $20.3M | $703.9M |
| Q4 25 | $66.8M | $892.9M | ||
| Q3 25 | $57.4M | $901.0M | ||
| Q2 25 | $58.2M | $903.2M | ||
| Q1 25 | $60.2M | $916.4M | ||
| Q4 24 | $64.8M | $946.9M | ||
| Q3 24 | $60.7M | $981.5M | ||
| Q2 24 | $65.4M | $1.0B | ||
| Q1 24 | $70.7M | $1.0B |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $3.8M |
| Free Cash FlowOCF − Capex | $-2.8M | $-12.7M |
| FCF MarginFCF / Revenue | -14.6% | -48.6% |
| Capex IntensityCapex / Revenue | 1.4% | 63.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-25.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $3.8M | ||
| Q3 25 | $-3.5M | $8.3M | ||
| Q2 25 | $-1.2M | $-2.9M | ||
| Q1 25 | $-702.0K | $-5.5M | ||
| Q4 24 | $-2.9M | $9.0M | ||
| Q3 24 | $-4.4M | $14.5M | ||
| Q2 24 | $-4.3M | $-648.0K | ||
| Q1 24 | $-6.3M | $-7.1M |
| Q4 25 | $-2.8M | $-12.7M | ||
| Q3 25 | $-4.1M | $3.0M | ||
| Q2 25 | $-1.5M | $-5.7M | ||
| Q1 25 | $-757.0K | $-9.9M | ||
| Q4 24 | $-3.2M | $-16.2M | ||
| Q3 24 | $-4.6M | $8.6M | ||
| Q2 24 | $-4.6M | $-5.1M | ||
| Q1 24 | $-6.4M | $-15.8M |
| Q4 25 | -14.6% | -48.6% | ||
| Q3 25 | -31.5% | 11.0% | ||
| Q2 25 | -13.2% | -21.5% | ||
| Q1 25 | -8.0% | -36.7% | ||
| Q4 24 | -22.4% | -57.2% | ||
| Q3 24 | -40.0% | 29.1% | ||
| Q2 24 | -38.0% | -16.7% | ||
| Q1 24 | -62.2% | -50.8% |
| Q4 25 | 1.4% | 63.0% | ||
| Q3 25 | 4.0% | 19.4% | ||
| Q2 25 | 2.3% | 10.7% | ||
| Q1 25 | 0.6% | 16.4% | ||
| Q4 24 | 1.7% | 88.9% | ||
| Q3 24 | 1.3% | 19.6% | ||
| Q2 24 | 2.4% | 14.6% | ||
| Q1 24 | 0.3% | 28.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
